Diagnostic Value of High-Sensitivity Cardiac Troponin-I in Patients After Out-of-Hospital Cardiac Arrest

Boaz Elad1, Doron Aronson2, Doron Cohn-Schwartz3

  • 1Department of Cardiology, Rambam Health Care Campus, Haifa, Israel.

PubMed

Insights

High-sensitivity cardiac troponin-I (hs-cTnI) levels, specifically peak levels and upslope, can help diagnose acute myocardial infarction (AMI) in out-of-hospital cardiac arrest (OHCA) survivors. These markers show good discrimination between AMI and non-AMI causes of OHCA.

Area of Science:

  • Cardiology
  • Biomarkers
  • Emergency Medicine

Background:

  • Determining the cause of cardiac arrest (CA) is crucial for effective treatment. Previous studies on cardiac troponin's diagnostic role in CA survivors yielded controversial results.
  • Few studies have investigated high-sensitivity cardiac troponin-I (hs-cTnI) during the current era, and its kinetic patterns post-CA remain underexplored.

Purpose of the Study:

  • To evaluate the diagnostic utility of hs-cTnI in patients who have been resuscitated from out-of-hospital cardiac arrest (OHCA).
  • To compare hs-cTnI levels and kinetics between patients with and without acute myocardial infarction (AMI) as the cause of OHCA.

Main Methods:

  • A retrospective analysis of 201 consecutive OHCA patients admitted to a cardiac intensive care unit between 2016 and 2021.
  • Patients were categorized into two groups: those with confirmed AMI and those without AMI as the cause of CA.
  • hs-cTnI levels at admission, peak levels, and the upslope of hs-cTnI were compared between the groups.

Main Results:

  • Significant differences were observed in peak hs-cTnI levels (median 1,424 vs 32,558 ng/L) and hs-cTnI upslope (median 109 vs 2,322 ng/L/h) between non-AMI and AMI groups (p < 0.0001 for both).
  • Peak hs-cTnI and hs-cTnI upslope demonstrated good discriminatory performance, with areas under the receiver operating characteristic curves of 0.83 and 0.80, respectively.

Conclusions:

  • Peak hs-cTnI levels and hs-cTnI upslope are valuable adjuncts for diagnosing the etiology of CA in OHCA survivors.
  • These hs-cTnI metrics can aid in differentiating between AMI and non-AMI causes of cardiac arrest, supporting clinical decision-making.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
185
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
110
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
19